Dr. Janet Scammell in the Faculty of Health and Social Sciences (FHSS) is leading on a new research project evaluating the impact of a new integrated respiratory service in Dorset.  The £20,000 mixed-methods research project is funded by the Wessex Academic Health Science Network on behalf of the Dorset Clinical Commissioning Group.  Janet Scammell is leading a research team in BU’s new Faculty of Health and Social Sciences comprising Desi Tait, Ashley Spriggs, Martin Hind, Caroline Belchamber and Edwin van Teijlingen.
The Dorset Adult Integrated Respiratory Service (DAIRS) is a new service that has been set up early 2014 to provide support and care for people with respiratory conditions such as chronic obstructive pulmonary disease (COPD), bronchiectasis and pulmonary fibrosis. The service aims to reduce the number of people who need admission to hospital and help individuals to feel more in control of their condition. BU has been asked to evaluate early uptake and impact of the DAIRS running in Poole, Bournemouth and Dorchester.
Further information about this exciting project is available from: Dr. Janet Scammell, Associate Professor and Professional Lead for Adult and Children & Young People’s Nursing
Telephone: 01202 962751
Email: jscammell@bournemouth.ac.uk
 BU awarded research grant to improve nurse retention
 FHSS PhD student awarded Civil Society Scholar Award (CSSA) by the Open Society Foundations
 FHSS Dr. Vanessa Heaslip awarded Florence Nightingale Travel Scholarship










 BU Festival of Social Sciences invite at RNLI
 MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
 Festival of Social Science: Introducing drowning prevention in Bangladesh
 BU PhD student attending HIV conference on scholarship
 ECR Funding Open Call: Research Culture & Community Grant – Apply Now
 MSCA Postdoctoral Fellowships 2025 Call
 ERC Advanced Grant 2025 Webinar
 Horizon Europe Work Programme 2025 Published
 Horizon Europe 2025 Work Programme pre-Published
 Update on UKRO services
 European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease